Gentis hopes to conquer spine market where others have failed
David Anderson says the road to developing an artificial spinal disc nucleus is littered with “spectacular failures.” But that doesn’t deter Anderson or his company, Philadelphia-based Gentis, from trying to be the first to get a disc nucleus replacement device for the lower spine on the U.S. market. The nucleus pulposus is the jelly-like substance […]